Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sitagliptin for the Prevention and Treatment of Hyperglycemia in Patients With Type 2 Diabetes Undergoing Cardiac Surgery

NCT02556918 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT02556918
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02556918 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sitagliptin for the Prevention and Treatment of Hyperglycemia in Patients With Type 2 Diabetes Undergoing Cardiac Surgery
Lead sponsor
Emory University
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2016
Completion date
November 6, 2018
Enrollment
202 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hyperglycemia